SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001493152-23-030408
Filing Date
2023-08-29
Accepted
2023-08-28 21:58:25
Documents
92

Document Format Files

Seq Description Document Type Size
1 forms-1a.htm   iXBRL S-1/A 4942813
2 ex23-1.htm EX-23.1 3807
3 logo_001.jpg GRAPHIC 7620
4 forms-1a_014.jpg GRAPHIC 86211
5 forms-1a_015.jpg GRAPHIC 95620
6 forms-1a_016.jpg GRAPHIC 70590
7 forms-1a_004.jpg GRAPHIC 191364
8 forms-1a_009.jpg GRAPHIC 163230
9 form10-12ga_001.jpg GRAPHIC 7914
10 forms-1a_017.jpg GRAPHIC 83686
11 forms-1_014.jpg GRAPHIC 7618
  Complete submission text file 0001493152-23-030408.txt   17746533

Data Files

Seq Description Document Type Size
12 XBRL SCHEMA FILE vtro-20230731.xsd EX-101.SCH 88384
13 XBRL CALCULATION FILE vtro-20230731_cal.xml EX-101.CAL 97394
14 XBRL DEFINITION FILE vtro-20230731_def.xml EX-101.DEF 353206
15 XBRL LABEL FILE vtro-20230731_lab.xml EX-101.LAB 692352
16 XBRL PRESENTATION FILE vtro-20230731_pre.xml EX-101.PRE 506111
85 EXTRACTED XBRL INSTANCE DOCUMENT forms-1a_htm.xml XML 2728644
Mailing Address 4621 TECHNOLOGY DRIVE GOLDEN CO 80403
Business Address 4621 TECHNOLOGY DRIVE GOLDEN CO 80403 (720) 859-4120
Vitro Biopharma, Inc. (Filer) CIK: 0000793171 (see all company filings)

IRS No.: 841012042 | State of Incorp.: NV | Fiscal Year End: 1031
Type: S-1/A | Act: 33 | File No.: 333-267366 | Film No.: 231217919
SIC: 2836 Biological Products, (No Diagnostic Substances)